US20180169403A1 - Nanowire arrays for neurotechnology and other applications - Google Patents
Nanowire arrays for neurotechnology and other applications Download PDFInfo
- Publication number
- US20180169403A1 US20180169403A1 US15/542,197 US201615542197A US2018169403A1 US 20180169403 A1 US20180169403 A1 US 20180169403A1 US 201615542197 A US201615542197 A US 201615542197A US 2018169403 A1 US2018169403 A1 US 2018169403A1
- Authority
- US
- United States
- Prior art keywords
- nanowires
- integrated circuit
- substrate
- cell
- article
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002070 nanowire Substances 0.000 title claims abstract description 394
- 238000003491 array Methods 0.000 title description 15
- 238000000034 method Methods 0.000 claims abstract description 142
- 210000004027 cell Anatomy 0.000 claims description 212
- 239000000758 substrate Substances 0.000 claims description 88
- 210000002569 neuron Anatomy 0.000 claims description 64
- 238000004891 communication Methods 0.000 claims description 52
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 46
- 239000010410 layer Substances 0.000 claims description 39
- 230000001537 neural effect Effects 0.000 claims description 26
- 210000004413 cardiac myocyte Anatomy 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 21
- 239000000377 silicon dioxide Substances 0.000 claims description 19
- 229910052751 metal Inorganic materials 0.000 claims description 18
- 239000002184 metal Substances 0.000 claims description 18
- 108090000862 Ion Channels Proteins 0.000 claims description 16
- 102000004310 Ion Channels Human genes 0.000 claims description 16
- 239000011241 protective layer Substances 0.000 claims description 16
- 229940000406 drug candidate Drugs 0.000 claims description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 14
- 229910052710 silicon Inorganic materials 0.000 claims description 14
- 239000010703 silicon Substances 0.000 claims description 14
- 238000000151 deposition Methods 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 claims description 10
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 claims description 10
- 239000004020 conductor Substances 0.000 claims description 10
- 238000004520 electroporation Methods 0.000 claims description 9
- 238000005530 etching Methods 0.000 claims description 9
- 238000002161 passivation Methods 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 8
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 229910052593 corundum Inorganic materials 0.000 claims description 3
- 229910001845 yogo sapphire Inorganic materials 0.000 claims description 3
- 229910052681 coesite Inorganic materials 0.000 claims 2
- 229910052906 cristobalite Inorganic materials 0.000 claims 2
- 229910052682 stishovite Inorganic materials 0.000 claims 2
- 229910052905 tridymite Inorganic materials 0.000 claims 2
- 238000005516 engineering process Methods 0.000 abstract description 10
- 230000003834 intracellular effect Effects 0.000 description 47
- 229910052720 vanadium Inorganic materials 0.000 description 40
- 239000000463 material Substances 0.000 description 36
- 230000036982 action potential Effects 0.000 description 30
- 230000000694 effects Effects 0.000 description 26
- 229940079593 drug Drugs 0.000 description 23
- 239000003814 drug Substances 0.000 description 23
- 230000000638 stimulation Effects 0.000 description 23
- 208000018737 Parkinson disease Diseases 0.000 description 21
- 239000012636 effector Substances 0.000 description 20
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 20
- 230000008569 process Effects 0.000 description 20
- 230000000670 limiting effect Effects 0.000 description 18
- 238000005259 measurement Methods 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 229920002120 photoresistant polymer Polymers 0.000 description 15
- -1 silicon dioxide) Chemical compound 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 239000004065 semiconductor Substances 0.000 description 13
- 230000008878 coupling Effects 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 210000004379 membrane Anatomy 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 208000012902 Nervous system disease Diseases 0.000 description 11
- 208000025966 Neurological disease Diseases 0.000 description 11
- 239000003990 capacitor Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000010931 gold Substances 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 239000010936 titanium Substances 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 210000003618 cortical neuron Anatomy 0.000 description 8
- 230000007831 electrophysiology Effects 0.000 description 8
- 238000002001 electrophysiology Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 8
- 229910052737 gold Inorganic materials 0.000 description 8
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 8
- 229910052697 platinum Inorganic materials 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 210000000170 cell membrane Anatomy 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 238000000231 atomic layer deposition Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 238000010172 mouse model Methods 0.000 description 6
- 230000001242 postsynaptic effect Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 235000012239 silicon dioxide Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000000946 synaptic effect Effects 0.000 description 6
- 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 5
- 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- 238000010009 beating Methods 0.000 description 5
- 230000006399 behavior Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000002051 biphasic effect Effects 0.000 description 5
- 230000009087 cell motility Effects 0.000 description 5
- 239000013626 chemical specie Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 5
- 238000000609 electron-beam lithography Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 229910000457 iridium oxide Inorganic materials 0.000 description 5
- 238000000206 photolithography Methods 0.000 description 5
- 238000001020 plasma etching Methods 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000004544 sputter deposition Methods 0.000 description 5
- 229910052719 titanium Inorganic materials 0.000 description 5
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 5
- 229910052721 tungsten Inorganic materials 0.000 description 5
- 239000010937 tungsten Substances 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910052581 Si3N4 Inorganic materials 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000007876 drug discovery Methods 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 4
- 230000020796 long term synaptic depression Effects 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000028161 membrane depolarization Effects 0.000 description 4
- 238000001465 metallisation Methods 0.000 description 4
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 4
- 229910010271 silicon carbide Inorganic materials 0.000 description 4
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 3
- 108010009685 Cholinergic Receptors Proteins 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 108010067306 Fibronectins Proteins 0.000 description 3
- 102000016359 Fibronectins Human genes 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 108010085895 Laminin Proteins 0.000 description 3
- 102000007547 Laminin Human genes 0.000 description 3
- 108010039918 Polylysine Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 102000034337 acetylcholine receptors Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 238000005229 chemical vapour deposition Methods 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000002508 contact lithography Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 210000001787 dendrite Anatomy 0.000 description 3
- URQUNWYOBNUYJQ-UHFFFAOYSA-N diazonaphthoquinone Chemical compound C1=CC=C2C(=O)C(=[N]=[N])C=CC2=C1 URQUNWYOBNUYJQ-UHFFFAOYSA-N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 239000003596 drug target Substances 0.000 description 3
- 238000005566 electron beam evaporation Methods 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000027928 long-term synaptic potentiation Effects 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002061 nanopillar Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920000656 polylysine Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 238000002207 thermal evaporation Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000001039 wet etching Methods 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 2
- 206010003805 Autism Diseases 0.000 description 2
- 208000020706 Autistic disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 2
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 2
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical group CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 2
- 150000001200 N-acyl ethanolamides Chemical class 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 229910000577 Silicon-germanium Inorganic materials 0.000 description 2
- 108010031318 Vitronectin Proteins 0.000 description 2
- 102100035140 Vitronectin Human genes 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000000423 cell based assay Methods 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000003229 cytophilic effect Effects 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000002621 endocannabinoid Substances 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 229910052733 gallium Inorganic materials 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 210000001153 interneuron Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000001459 lithography Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000007171 neuropathology Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 229910052755 nonmetal Inorganic materials 0.000 description 2
- 210000001517 olfactory receptor neuron Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- 229920003209 poly(hydridosilsesquioxane) Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003518 presynaptic effect Effects 0.000 description 2
- 230000002336 repolarization Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000003956 synaptic plasticity Effects 0.000 description 2
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- LPWZCJFZJCOBHO-UHFFFAOYSA-N 11-triethoxysilylundecan-1-amine Chemical compound CCO[Si](OCC)(OCC)CCCCCCCCCCCN LPWZCJFZJCOBHO-UHFFFAOYSA-N 0.000 description 1
- VHJRQDUWYYJDBE-UHFFFAOYSA-N 11-trimethoxysilylundecane-1-thiol Chemical compound CO[Si](OC)(OC)CCCCCCCCCCCS VHJRQDUWYYJDBE-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- IYAYDWLKTPIEDC-UHFFFAOYSA-N 2-[2-hydroxyethyl(3-triethoxysilylpropyl)amino]ethanol Chemical compound CCO[Si](OCC)(OCC)CCCN(CCO)CCO IYAYDWLKTPIEDC-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- HXLAEGYMDGUSBD-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propan-1-amine Chemical compound CCO[Si](C)(OCC)CCCN HXLAEGYMDGUSBD-UHFFFAOYSA-N 0.000 description 1
- GLISZRPOUBOZDL-UHFFFAOYSA-N 3-bromopropyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)CCCBr GLISZRPOUBOZDL-UHFFFAOYSA-N 0.000 description 1
- DOGMJCPBZJUYGB-UHFFFAOYSA-N 3-trichlorosilylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](Cl)(Cl)Cl DOGMJCPBZJUYGB-UHFFFAOYSA-N 0.000 description 1
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- 101000583076 Anemonia sulcata Delta-actitoxin-Avd1c Proteins 0.000 description 1
- 101001023065 Anemonia viridis Delta-actitoxin-Avd1e 2 Proteins 0.000 description 1
- 101001023066 Anemonia viridis Delta-actitoxin-Avd1e 3 Proteins 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000064494 Diplobatis ommata Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229910002601 GaN Inorganic materials 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- JMASRVWKEDWRBT-UHFFFAOYSA-N Gallium nitride Chemical compound [Ga]#N JMASRVWKEDWRBT-UHFFFAOYSA-N 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 241001417101 Gymnotidae Species 0.000 description 1
- 101000694017 Homo sapiens Sodium channel protein type 5 subunit alpha Proteins 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910018557 Si O Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910003086 Ti–Pt Inorganic materials 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- LEVVHYCKPQWKOP-UHFFFAOYSA-N [Si].[Ge] Chemical compound [Si].[Ge] LEVVHYCKPQWKOP-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- LZAXPYOBKSJSEX-UHFFFAOYSA-N blebbistatin Chemical compound C1CC2(O)C(=O)C3=CC(C)=CC=C3N=C2N1C1=CC=CC=C1 LZAXPYOBKSJSEX-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 108010015046 cell aggregation factors Proteins 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 210000005064 dopaminergic neuron Anatomy 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000007878 drug screening assay Methods 0.000 description 1
- 238000001312 dry etching Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 239000012799 electrically-conductive coating Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 230000034964 establishment of cell polarity Effects 0.000 description 1
- HHBOIIOOTUCYQD-UHFFFAOYSA-N ethoxy-dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(C)CCCOCC1CO1 HHBOIIOOTUCYQD-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 208000015700 familial long QT syndrome Diseases 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(iv) oxide Chemical compound O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 125000005179 haloacetyl group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 150000002411 histidines Chemical class 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003093 intracellular space Anatomy 0.000 description 1
- 231100000666 ion channel toxin Toxicity 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000011173 large scale experimental method Methods 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000004731 long QT syndrome Diseases 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000000897 modulatory effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 1
- MQWFLKHKWJMCEN-UHFFFAOYSA-N n'-[3-[dimethoxy(methyl)silyl]propyl]ethane-1,2-diamine Chemical compound CO[Si](C)(OC)CCCNCCN MQWFLKHKWJMCEN-UHFFFAOYSA-N 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- CAPBXYLOGXJCFU-UHFFFAOYSA-N oxiran-2-ylmethoxysilane Chemical class [SiH3]OCC1CO1 CAPBXYLOGXJCFU-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000012402 patch clamp technique Methods 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000012910 preclinical development Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000001567 regular cardiac muscle cell of ventricle Anatomy 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920002631 room-temperature vulcanizate silicone Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical class [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 239000013464 silicone adhesive Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- TXDNPSYEJHXKMK-UHFFFAOYSA-N sulfanylsilane Chemical class S[SiH3] TXDNPSYEJHXKMK-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010301 surface-oxidation reaction Methods 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- DOEHJNBEOVLHGL-UHFFFAOYSA-N trichloro(propyl)silane Chemical compound CCC[Si](Cl)(Cl)Cl DOEHJNBEOVLHGL-UHFFFAOYSA-N 0.000 description 1
- UMFJXASDGBJDEB-UHFFFAOYSA-N triethoxy(prop-2-enyl)silane Chemical compound CCO[Si](CC=C)(OCC)OCC UMFJXASDGBJDEB-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- UBMUZYGBAGFCDF-UHFFFAOYSA-N trimethoxy(2-phenylethyl)silane Chemical compound CO[Si](OC)(OC)CCC1=CC=CC=C1 UBMUZYGBAGFCDF-UHFFFAOYSA-N 0.000 description 1
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 1
- ZNOCGWVLWPVKAO-UHFFFAOYSA-N trimethoxy(phenyl)silane Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1 ZNOCGWVLWPVKAO-UHFFFAOYSA-N 0.000 description 1
- LFRDHGNFBLIJIY-UHFFFAOYSA-N trimethoxy(prop-2-enyl)silane Chemical compound CO[Si](OC)(OC)CC=C LFRDHGNFBLIJIY-UHFFFAOYSA-N 0.000 description 1
- PZJJKWKADRNWSW-UHFFFAOYSA-N trimethoxysilicon Chemical compound CO[Si](OC)OC PZJJKWKADRNWSW-UHFFFAOYSA-N 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0531—Brain cortex electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0536—Preventing neurodegenerative response or inflammatory reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
- G01N33/4836—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures using multielectrode arrays
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/48—Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/48—Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor
- H01L23/488—Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor consisting of soldered or bonded constructions
- H01L23/49—Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor consisting of soldered or bonded constructions wire-like arrangements or pins or rods
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L29/00—Semiconductor devices adapted for rectifying, amplifying, oscillating or switching, or capacitors or resistors with at least one potential-jump barrier or surface barrier, e.g. PN junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof ; Multistep manufacturing processes therefor
- H01L29/02—Semiconductor bodies ; Multistep manufacturing processes therefor
- H01L29/06—Semiconductor bodies ; Multistep manufacturing processes therefor characterised by their shape; characterised by the shapes, relative sizes, or dispositions of the semiconductor regions ; characterised by the concentration or distribution of impurities within semiconductor regions
- H01L29/0657—Semiconductor bodies ; Multistep manufacturing processes therefor characterised by their shape; characterised by the shapes, relative sizes, or dispositions of the semiconductor regions ; characterised by the concentration or distribution of impurities within semiconductor regions characterised by the shape of the body
- H01L29/0665—Semiconductor bodies ; Multistep manufacturing processes therefor characterised by their shape; characterised by the shapes, relative sizes, or dispositions of the semiconductor regions ; characterised by the concentration or distribution of impurities within semiconductor regions characterised by the shape of the body the shape of the body defining a nanostructure
- H01L29/0669—Nanowires or nanotubes
- H01L29/0676—Nanowires or nanotubes oriented perpendicular or at an angle to a substrate
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/0001—Technical content checked by a classifier
- H01L2924/0002—Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/10—Details of semiconductor or other solid state devices to be connected
- H01L2924/102—Material of the semiconductor or solid state bodies
- H01L2924/1025—Semiconducting materials
- H01L2924/10251—Elemental semiconductors, i.e. Group IV
- H01L2924/10253—Silicon [Si]
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/10—Details of semiconductor or other solid state devices to be connected
- H01L2924/11—Device type
- H01L2924/14—Integrated circuits
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Neurology (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nanotechnology (AREA)
- General Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Computer Hardware Design (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Psychology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Materials Engineering (AREA)
- Ceramic Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/542,197 US20180169403A1 (en) | 2015-01-09 | 2016-01-08 | Nanowire arrays for neurotechnology and other applications |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562101931P | 2015-01-09 | 2015-01-09 | |
| US201562126402P | 2015-02-27 | 2015-02-27 | |
| US15/542,197 US20180169403A1 (en) | 2015-01-09 | 2016-01-08 | Nanowire arrays for neurotechnology and other applications |
| PCT/US2016/012685 WO2016112315A2 (fr) | 2015-01-09 | 2016-01-08 | Réseaux de nanofils pour la neurotechnologie et d'autres applications |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2016/012685 A-371-Of-International WO2016112315A2 (fr) | 2015-01-09 | 2016-01-08 | Réseaux de nanofils pour la neurotechnologie et d'autres applications |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/144,387 Continuation US11833346B2 (en) | 2015-01-09 | 2021-01-08 | Integrated circuits for neurotechnology and other applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20180169403A1 true US20180169403A1 (en) | 2018-06-21 |
Family
ID=56356579
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/542,197 Abandoned US20180169403A1 (en) | 2015-01-09 | 2016-01-08 | Nanowire arrays for neurotechnology and other applications |
| US17/144,387 Active 2036-07-08 US11833346B2 (en) | 2015-01-09 | 2021-01-08 | Integrated circuits for neurotechnology and other applications |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/144,387 Active 2036-07-08 US11833346B2 (en) | 2015-01-09 | 2021-01-08 | Integrated circuits for neurotechnology and other applications |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US20180169403A1 (fr) |
| WO (1) | WO2016112315A2 (fr) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022117880A2 (fr) | 2020-12-04 | 2022-06-09 | Centre National De La Recherche Scientifique (Cnrs) | Plateforme de nanostructures pour l'interfaçage cellulaire et procédé de fabrication correspondant |
| FR3117101A1 (fr) | 2020-12-04 | 2022-06-10 | Centre National De La Recherche Scientifique (Cnrs) | Plateforme de nanostructures pour l’interfaçage cellulaire et procédé de fabrication correspondant |
| US11651188B1 (en) * | 2018-11-21 | 2023-05-16 | CCLabs Pty Ltd | Biological computing platform |
| US11747321B2 (en) | 2020-06-17 | 2023-09-05 | President And Fellows Of Harvard College | Apparatuses for cell mapping via impedance measurements and methods to operate the same |
| US11768196B2 (en) | 2017-07-07 | 2023-09-26 | President And Fellows Of Harvard College | Current-based stimulators for electrogenic cells and related methods |
| US11774396B2 (en) | 2020-06-17 | 2023-10-03 | President And Fellows Of Harvard College | Systems and methods for patterning and spatial electrochemical mapping of cells |
| US11833346B2 (en) | 2015-01-09 | 2023-12-05 | President And Fellows Of Harvard College | Integrated circuits for neurotechnology and other applications |
| US11898135B1 (en) | 2019-07-01 | 2024-02-13 | CCLabs Pty Ltd | Closed-loop perfusion circuit for cell and tissue cultures |
| EP4170742A4 (fr) * | 2020-06-23 | 2024-02-21 | Consejo Superior Investigacion | Électrodes nanostructurées pour la stimulation électrique de cellules en culture, dispositifs, systèmes et procédés associés |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200292482A1 (en) * | 2017-11-01 | 2020-09-17 | President And Fellows Of Harvard College | Electronic circuits for analyzing electrogenic cells and related methods |
| US20200347393A1 (en) * | 2017-12-08 | 2020-11-05 | President And Fellows Of Harvard College | Micro- and nanoneedles for plant and other cell penetration |
| US20210093246A1 (en) * | 2018-05-10 | 2021-04-01 | The Regents Of The University Of California | Sharp, vertically aligned nanowire electrode arrays, high-yield fabrication and intracellular recording |
| US11946894B2 (en) * | 2022-02-16 | 2024-04-02 | Western Digital Technologies, Inc. | Low noise amplifiers with feedback for nanopore applications |
| US11940404B2 (en) | 2022-02-16 | 2024-03-26 | Western Digital Technologies, Inc. | Low noise amplifiers with shields for nanopore Applications |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751471A (en) * | 1985-08-21 | 1988-06-14 | Spring Creek Institute, Inc. | Amplifying circuit particularly adapted for amplifying a biopotential input signal |
| US20070187840A1 (en) * | 2005-11-21 | 2007-08-16 | Dell Acqua-Bellavitis Ludovico | Nanoscale probes for electrophysiological applications |
| US20080238552A1 (en) * | 2007-03-30 | 2008-10-02 | Matsushita Electric Industrial Co., Ltd. | Semiconductor device |
| US20090295480A1 (en) * | 2008-05-28 | 2009-12-03 | Kabushiki Kaisha Nihon Micronics | Amplifier circuit |
| US20110210718A1 (en) * | 2010-02-26 | 2011-09-01 | Dionex Corporation | Analytic Device With PhotoVoltaic Power Source |
| US20110233512A1 (en) * | 2005-08-16 | 2011-09-29 | The Regents Of The University Of California | Vertical integrated silicon nanowire field effect transistors and methods of fabrication |
| US20110253982A1 (en) * | 2008-10-28 | 2011-10-20 | The Regents Of The University Of California | Vertical group iii-v nanowires on si, heterostructures, flexible arrays and fabrication |
| US20110291643A1 (en) * | 2010-06-01 | 2011-12-01 | Georgia Tech Researh Corporation | Modular nano and microscale sensors |
| US20120157804A1 (en) * | 2009-12-16 | 2012-06-21 | Rogers John A | High-Speed, High-Resolution Electrophysiology In-Vivo Using Conformal Electronics |
| US20130072775A1 (en) * | 2011-06-03 | 2013-03-21 | John Rogers | Conformable Actively Multiplexed High-Density Surface Electrode Array for Brain Interfacing |
Family Cites Families (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2651389A1 (fr) | 1989-08-25 | 1991-03-01 | Radiotechnique Compelec | Amplificateur differentiel a couplage capacitif. |
| US5233985A (en) | 1990-08-10 | 1993-08-10 | Medtronic, Inc. | Cardiac pacemaker with operational amplifier output circuit |
| JP2697474B2 (ja) | 1992-04-30 | 1998-01-14 | 松下電器産業株式会社 | 微細構造の製造方法 |
| US5605612A (en) | 1993-11-11 | 1997-02-25 | Goldstar Electron Co., Ltd. | Gas sensor and manufacturing method of the same |
| US5688642A (en) | 1994-12-01 | 1997-11-18 | The United States Of America As Represented By The Secretary Of The Navy | Selective attachment of nucleic acid molecules to patterned self-assembled surfaces |
| DE19529371C3 (de) | 1995-08-10 | 2003-05-28 | Nmi Univ Tuebingen | Mikroelektroden-Anordnung |
| JPH10106960A (ja) | 1996-09-25 | 1998-04-24 | Sony Corp | 量子細線の製造方法 |
| JPH10234366A (ja) | 1997-02-26 | 1998-09-08 | Hisamitsu Pharmaceut Co Inc | エレクトロポレーション用電極及びその製法、それを用いた製剤 |
| US6123819A (en) | 1997-11-12 | 2000-09-26 | Protiveris, Inc. | Nanoelectrode arrays |
| US6683446B1 (en) | 1998-12-22 | 2004-01-27 | John Pope | Electrode array for development and testing of materials |
| US6713291B2 (en) | 1999-01-28 | 2004-03-30 | Alan D. King | Electrodes coated with treating agent and uses thereof |
| TW403969B (en) | 1999-04-09 | 2000-09-01 | United Microelectronics Corp | Method for manufacturing metal oxide semiconductor |
| US7053063B2 (en) | 1999-07-21 | 2006-05-30 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes in tissue |
| US6286226B1 (en) | 1999-09-24 | 2001-09-11 | Agere Systems Guardian Corp. | Tactile sensor comprising nanowires and method for making the same |
| EP1266218A2 (fr) | 2000-03-15 | 2002-12-18 | Aviva Biosciences Corporation | Appareil et procede pour l'analyse par electrorotation a haut rendement |
| AU2001264759B2 (en) | 2000-05-22 | 2006-06-01 | Merck & Co., Inc. | System and method for assessing the performance of a pharmaceutical agent delivery system |
| US6951715B2 (en) | 2000-10-30 | 2005-10-04 | Sru Biosystems, Inc. | Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements |
| US7332313B2 (en) | 2001-06-05 | 2008-02-19 | Applied Biophysics, Inc. | Electrical wounding assay for cells in vitro |
| EP1271144A1 (fr) | 2001-06-27 | 2003-01-02 | flyion GmbH | Méthode et circuit de contrôle et mesure de paramètres électriques dans une membrane biologique |
| TW506083B (en) * | 2001-11-28 | 2002-10-11 | Ind Tech Res Inst | Method of using nano-tube to increase semiconductor device capacitance |
| US20030189202A1 (en) | 2002-04-05 | 2003-10-09 | Jun Li | Nanowire devices and methods of fabrication |
| US8206903B2 (en) | 2002-12-20 | 2012-06-26 | Acea Biosciences | Device and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses |
| US7470533B2 (en) | 2002-12-20 | 2008-12-30 | Acea Biosciences | Impedance based devices and methods for use in assays |
| US7560269B2 (en) | 2002-12-20 | 2009-07-14 | Acea Biosciences, Inc. | Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays |
| WO2004034025A2 (fr) | 2002-10-10 | 2004-04-22 | Nanosys, Inc. | Biocapteurs sur transistors a effet de champ a nanostructure chimique |
| AU2003278461A1 (en) | 2002-10-16 | 2004-05-04 | Cellectricon Ab | Nanoelectrodes and nanotips for recording transmembrane currents in a plurality of cells |
| US7163659B2 (en) | 2002-12-03 | 2007-01-16 | Hewlett-Packard Development Company, L.P. | Free-standing nanowire sensor and method for detecting an analyte in a fluid |
| US8993327B2 (en) | 2003-04-07 | 2015-03-31 | Ut-Battelle, Llc | Parallel macromolecular delivery and biochemical/electrochemical interface to cells employing nanostructures |
| US20050221072A1 (en) | 2003-04-17 | 2005-10-06 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
| EP1634075B1 (fr) | 2003-06-10 | 2015-01-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dispositif electronique permettant de communiquer avec des cellules vivantes |
| US7276351B2 (en) | 2003-09-10 | 2007-10-02 | Seahorse Bioscience | Method and device for measuring multiple physiological properties of cells |
| US20070087401A1 (en) | 2003-10-17 | 2007-04-19 | Andy Neilson | Analysis of metabolic activity in cells using extracellular flux rate measurements |
| US20050253137A1 (en) | 2003-11-20 | 2005-11-17 | President And Fellows Of Harvard College | Nanoscale arrays, robust nanostructures, and related devices |
| WO2005066342A1 (fr) | 2003-12-01 | 2005-07-21 | Walters Richard E | Chambre a champ electrique non uniforme pour fusion cellulaire |
| WO2005056788A1 (fr) | 2003-12-08 | 2005-06-23 | Excellin Life Sciences, Inc. | Dispositif et procede d'electroporation et d'apports moleculaires regules a des cellules et des tissus |
| CN100497641C (zh) | 2004-01-29 | 2009-06-10 | 拜欧斯拉伯(股份)责任有限公司 | 生物芯片电穿孔仪及其在全方位单细胞电穿孔中应用 |
| WO2005093831A1 (fr) | 2004-02-13 | 2005-10-06 | President And Fellows Of Harvard College | Nanostructures contenant des composants metal/semi-conducteur |
| US7169609B2 (en) | 2004-03-31 | 2007-01-30 | Vertex Pharmaceutcals, Inc. | Multiwell plate assembly for use in high throughput assays |
| US20050279274A1 (en) | 2004-04-30 | 2005-12-22 | Chunming Niu | Systems and methods for nanowire growth and manufacturing |
| US8932850B2 (en) | 2004-06-12 | 2015-01-13 | Invitrogen Singapore Pte. Ltd. | Electroporation apparatus having an elongated hollow member |
| US7786086B2 (en) * | 2004-09-08 | 2010-08-31 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
| WO2006124055A2 (fr) | 2004-10-12 | 2006-11-23 | Nanosys, Inc. | Procedes en couches organiques completement integrees destines a la fabrication de materiel electronique en plastique se basant sur des polymeres conducteurs et sur des nanofils semi-conducteurs |
| US7875280B2 (en) | 2004-12-02 | 2011-01-25 | The University Of Chicago | Methods and compositions involving LcrV proteins |
| US20060275800A1 (en) | 2005-04-29 | 2006-12-07 | Doecke Wolf D | Process for characterization of the transactivation and transrepression activity of glucocorticoid receptor ligands in primary immune cells |
| DE102005030859A1 (de) | 2005-07-01 | 2007-01-04 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Elektrodenanordnung, deren Verwendung sowie Verfahren zu deren Herstellung |
| EP1941537A4 (fr) | 2005-10-20 | 2010-03-31 | Univ Ohio State | Apport de medicament et de genes par timbre cellulaire a nanobuses et nanopointes polymeres |
| EP2049436B1 (fr) | 2006-08-11 | 2012-10-17 | Agency for Science, Technology and Research | Capteur à nanofil, réseau de capteurs à nanofils et leur méthode de fabrication |
| US7803707B2 (en) * | 2006-08-17 | 2010-09-28 | Wisconsin Alumni Research Foundation | Metal silicide nanowires and methods for their production |
| US20080218939A1 (en) | 2007-03-09 | 2008-09-11 | Marcus Matthew S | Nanowire supercapacitor electrode |
| JP2008269725A (ja) | 2007-04-23 | 2008-11-06 | Sharp Corp | 電気的特性評価装置 |
| DE102007019842A1 (de) | 2007-04-25 | 2008-10-30 | Forschungsinstitut Für Die Biologie Landwirtschaftlicher Nutztiere | Verfahren und Anordnung zum elektrischen Kontaktieren eines membranumhüllten Objekts mit einer Elektrode |
| JP5022789B2 (ja) | 2007-06-27 | 2012-09-12 | ザインエレクトロニクス株式会社 | 信号変換回路及びレール・ツー・レール回路 |
| CA2700552A1 (fr) | 2007-10-15 | 2009-04-23 | Universite Catholique De Louvain | Reseau de nanofils a elution de medicament |
| US8319002B2 (en) | 2007-12-06 | 2012-11-27 | Nanosys, Inc. | Nanostructure-enhanced platelet binding and hemostatic structures |
| US8361297B2 (en) | 2008-01-11 | 2013-01-29 | The Penn State Research Foundation | Bottom-up assembly of structures on a substrate |
| US20100330612A1 (en) | 2008-02-21 | 2010-12-30 | Inxell Bionics Aps | Biochip for electrophysiological measurements |
| US7709325B2 (en) | 2008-03-06 | 2010-05-04 | International Business Machines Corporation | Method of forming ring electrode |
| EP2252545A2 (fr) | 2008-03-10 | 2010-11-24 | Yeda Research And Development Company Ltd. | Procédé de fabrication de surfaces formées en motif d échelle nanométrique |
| US20090255801A1 (en) | 2008-04-11 | 2009-10-15 | Haas Alfred M | Programmable Electrode Arrays and Methods for Manipulating and Sensing Cells and Substances Using Same |
| EP2291645B1 (fr) | 2008-05-05 | 2015-09-09 | Acea Biosciences, Inc. | Surveillance sans marqueur d'un couplage excitation-contraction et cellules pouvant être excitées utilisant des systèmes fondés sur l'impédance avec une résolution dans le temps de l'ordre de la milliseconde |
| US20090312194A1 (en) | 2008-06-13 | 2009-12-17 | Oregon Health & Science University | Selection of personalized cancer therapy regimens using interfering rna functional screening |
| WO2010003062A2 (fr) | 2008-07-03 | 2010-01-07 | The Regents Of The University Of California | Matériaux biologiques et implants pour une formation améliorée de cartilage, et procédés de fabrication et d’utilisation de ceux-ci |
| ES2574137T3 (es) | 2008-09-03 | 2016-06-15 | Quantumdx Group Limited | Estrategias y métodos de detección de ácidos nucleicos mediante biosensores |
| US9000353B2 (en) | 2010-06-22 | 2015-04-07 | President And Fellows Of Harvard College | Light absorption and filtering properties of vertically oriented semiconductor nano wires |
| US8227223B2 (en) | 2009-01-27 | 2012-07-24 | Applied Biophysics, Inc. | Method and apparatus for facilitating evaluating migration of cells in vitro |
| US8148264B2 (en) | 2009-02-25 | 2012-04-03 | California Institue Of Technology | Methods for fabrication of high aspect ratio micropillars and nanopillars |
| US9304132B2 (en) * | 2009-04-16 | 2016-04-05 | President And Fellows Of Harvard College | Molecular delivery with nanowires |
| EP2447354B1 (fr) | 2009-06-23 | 2018-08-15 | Hitachi, Ltd. | Substrat de culture, feuille de culture, et procédé de culture cellulaire |
| US9101566B2 (en) | 2009-06-25 | 2015-08-11 | Kirin Holdings Kabushiki Kaisha | Fermentation product of cereal plant-derived material and immunomodulator |
| EP2284252A1 (fr) | 2009-08-13 | 2011-02-16 | Sony DADC Austria AG | Dispositif structuré en surface pour applications de sciences biologiques |
| US10441185B2 (en) | 2009-12-16 | 2019-10-15 | The Board Of Trustees Of The University Of Illinois | Flexible and stretchable electronic systems for epidermal electronics |
| IL206241A0 (en) * | 2010-06-08 | 2010-12-30 | Fernando Patolsky | Modified nanowires for use in detecting nitro - containing chemicals |
| EP2621584B1 (fr) | 2010-09-29 | 2015-01-14 | President and Fellows of Harvard College | Nanowires destinés à des applications électrophysiologiques |
| WO2012050881A2 (fr) | 2010-09-29 | 2012-04-19 | President And Fellows Of Harvard College | Dispositif de distribution moléculaire doté de nanofils |
| US20140001041A1 (en) | 2010-11-08 | 2014-01-02 | Agency For Science, Technology And Research | Biosensor |
| WO2012082803A2 (fr) | 2010-12-13 | 2012-06-21 | Cel-Sci Corporation | Procédé pour induire une réponse immunitaire contre les virus de la grippe aviaire, porcine, espagnole, h1n1, h5n9 et leurs formulations |
| US8410962B2 (en) | 2011-01-19 | 2013-04-02 | Analog Devices, Inc. | Active RC resonators with enhanced Q factor |
| US9096942B2 (en) | 2011-02-22 | 2015-08-04 | Massachusetts Institute Of Technology | Electrophoretic-deposited surfaces |
| US9789313B2 (en) | 2011-02-23 | 2017-10-17 | John D. LIPANI | System and methods for diagnosis and treatment of discogenic lower back pain |
| KR101559096B1 (ko) | 2011-07-20 | 2015-10-08 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 나노포어 폴리뉴클레오티드 서열분석용 보상 패치-클램프 증폭기 및 기타 용도 |
| WO2013192083A2 (fr) | 2012-06-18 | 2013-12-27 | Axion Biosystems, Inc. | Dispositif à microélectrode 3d pour applications à des tissus vivants |
| EP2677307B1 (fr) | 2012-06-21 | 2016-05-11 | Nxp B.V. | Circuit intégré avec capteurs de pression et procédé de fabrication |
| US20150197807A1 (en) | 2012-08-20 | 2015-07-16 | Presidents And Fellows Of Harvard College | Use of nanowires for delivering biological effectors into immune cells |
| WO2014031172A1 (fr) | 2012-08-22 | 2014-02-27 | President And Fellows Of Harvard College | Fabrication de réseaux de nanofils |
| US9700221B2 (en) | 2013-03-06 | 2017-07-11 | Axion Biosystems, Inc. | Non-invasive segmentable three-dimensional microelectrode array patch for neurophysiological diagnostics and therapeutic stimulation |
| US9279801B2 (en) | 2013-07-26 | 2016-03-08 | Axion Biosystems, Inc. | Devices, systems and methods for high-throughput electrophysiology |
| JP2018027018A (ja) | 2013-08-27 | 2018-02-22 | クオンタムバイオシステムズ株式会社 | 生体分子熱変性装置及びその製造方法 |
| US9885012B2 (en) | 2013-11-05 | 2018-02-06 | Axion Biosystems, Inc. | Devices, systems, and methods for targeted plating of materials in high-throughput culture plates |
| WO2015076444A1 (fr) | 2013-11-25 | 2015-05-28 | (주)와이브레인 | Système de mesure d'onde cérébrale et de stimulation cérébrale |
| US10959631B2 (en) | 2014-02-01 | 2021-03-30 | Biocircuit Technologies, Inc. | Neural interfacing device |
| EP3092474B1 (fr) | 2014-06-12 | 2020-04-22 | Axion Biosystems, Inc. | Réseau de microélectrodes multipuits à stimulation optique |
| US10067117B2 (en) | 2014-08-12 | 2018-09-04 | Axion Biosystems, Inc. | Cell-based biosensor array and associated methods for manufacturing the same |
| US20180169403A1 (en) | 2015-01-09 | 2018-06-21 | President And Fellows Of Harvard College | Nanowire arrays for neurotechnology and other applications |
| US9983198B2 (en) | 2015-03-19 | 2018-05-29 | Axion Biosystems, Inc. | Systems and methods for assessing data collected from an electrically active cell culture |
| US20160278713A1 (en) | 2015-03-25 | 2016-09-29 | Ecole Polytechnique Federale De Lausanne (Epfl) | Compact low-power recording architecture for multichannel acquisition of biological signals and method for compressing said biological signal data |
| US10351812B2 (en) | 2015-08-28 | 2019-07-16 | Axion Biosystems, Inc. | Device and system for creating and maintaining a localized environment for a cell culture plate |
| US10591462B2 (en) | 2016-03-03 | 2020-03-17 | Mohammad Abdolahad | Electrochemical method and device for detecting the effect of anticancer drugs |
| JP6344775B2 (ja) | 2016-05-20 | 2018-06-20 | 国立大学法人東北大学 | 電気化学イメージング方法、電気化学測定装置及びトランスデューサ |
| US10994130B2 (en) | 2016-09-06 | 2021-05-04 | Biocircuit Technologies, Inc. | Devices and methods for repairing damage to a nerve |
| US11768196B2 (en) | 2017-07-07 | 2023-09-26 | President And Fellows Of Harvard College | Current-based stimulators for electrogenic cells and related methods |
| US20200292482A1 (en) | 2017-11-01 | 2020-09-17 | President And Fellows Of Harvard College | Electronic circuits for analyzing electrogenic cells and related methods |
| US11175281B2 (en) | 2018-08-21 | 2021-11-16 | International Business Machines Corporation | Well plate cover with embedded electronic sensors for monitoring cell metabolism |
| JP2023530700A (ja) | 2020-06-17 | 2023-07-19 | プレジデント アンド フェローズ オブ ハーバード カレッジ | インピーダンス測定による細胞マッピングのための装置およびその動作方法 |
| CN116075722A (zh) | 2020-06-17 | 2023-05-05 | 哈佛学院院长及董事 | 用于细胞电评估的互补金属氧化物半导体（cmos）多阱装置 |
| EP4168172A1 (fr) | 2020-06-17 | 2023-04-26 | President and Fellows of Harvard College | Systèmes et procédés de formation de motifs et de cartographie électrochimique spatiale de cellules |
-
2016
- 2016-01-08 US US15/542,197 patent/US20180169403A1/en not_active Abandoned
- 2016-01-08 WO PCT/US2016/012685 patent/WO2016112315A2/fr active Application Filing
-
2021
- 2021-01-08 US US17/144,387 patent/US11833346B2/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751471A (en) * | 1985-08-21 | 1988-06-14 | Spring Creek Institute, Inc. | Amplifying circuit particularly adapted for amplifying a biopotential input signal |
| US20110233512A1 (en) * | 2005-08-16 | 2011-09-29 | The Regents Of The University Of California | Vertical integrated silicon nanowire field effect transistors and methods of fabrication |
| US20070187840A1 (en) * | 2005-11-21 | 2007-08-16 | Dell Acqua-Bellavitis Ludovico | Nanoscale probes for electrophysiological applications |
| US20080238552A1 (en) * | 2007-03-30 | 2008-10-02 | Matsushita Electric Industrial Co., Ltd. | Semiconductor device |
| US20090295480A1 (en) * | 2008-05-28 | 2009-12-03 | Kabushiki Kaisha Nihon Micronics | Amplifier circuit |
| US20110253982A1 (en) * | 2008-10-28 | 2011-10-20 | The Regents Of The University Of California | Vertical group iii-v nanowires on si, heterostructures, flexible arrays and fabrication |
| US20120157804A1 (en) * | 2009-12-16 | 2012-06-21 | Rogers John A | High-Speed, High-Resolution Electrophysiology In-Vivo Using Conformal Electronics |
| US20110210718A1 (en) * | 2010-02-26 | 2011-09-01 | Dionex Corporation | Analytic Device With PhotoVoltaic Power Source |
| US20110291643A1 (en) * | 2010-06-01 | 2011-12-01 | Georgia Tech Researh Corporation | Modular nano and microscale sensors |
| US20130072775A1 (en) * | 2011-06-03 | 2013-03-21 | John Rogers | Conformable Actively Multiplexed High-Density Surface Electrode Array for Brain Interfacing |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11833346B2 (en) | 2015-01-09 | 2023-12-05 | President And Fellows Of Harvard College | Integrated circuits for neurotechnology and other applications |
| US11768196B2 (en) | 2017-07-07 | 2023-09-26 | President And Fellows Of Harvard College | Current-based stimulators for electrogenic cells and related methods |
| US11651188B1 (en) * | 2018-11-21 | 2023-05-16 | CCLabs Pty Ltd | Biological computing platform |
| US11898135B1 (en) | 2019-07-01 | 2024-02-13 | CCLabs Pty Ltd | Closed-loop perfusion circuit for cell and tissue cultures |
| US11747321B2 (en) | 2020-06-17 | 2023-09-05 | President And Fellows Of Harvard College | Apparatuses for cell mapping via impedance measurements and methods to operate the same |
| US11774396B2 (en) | 2020-06-17 | 2023-10-03 | President And Fellows Of Harvard College | Systems and methods for patterning and spatial electrochemical mapping of cells |
| EP4170742A4 (fr) * | 2020-06-23 | 2024-02-21 | Consejo Superior Investigacion | Électrodes nanostructurées pour la stimulation électrique de cellules en culture, dispositifs, systèmes et procédés associés |
| WO2022117880A2 (fr) | 2020-12-04 | 2022-06-09 | Centre National De La Recherche Scientifique (Cnrs) | Plateforme de nanostructures pour l'interfaçage cellulaire et procédé de fabrication correspondant |
| FR3117101A1 (fr) | 2020-12-04 | 2022-06-10 | Centre National De La Recherche Scientifique (Cnrs) | Plateforme de nanostructures pour l’interfaçage cellulaire et procédé de fabrication correspondant |
| FR3117102A1 (fr) | 2020-12-04 | 2022-06-10 | Centre National De La Recherche Scientifique (Cnrs) | Plateforme de nanostructures pour l’interfaçage cellulaire et procédé de fabrication correspondant |
| WO2022117880A3 (fr) * | 2020-12-04 | 2022-08-25 | Centre National De La Recherche Scientifique (Cnrs) | Plateforme de nanostructures pour l'interfaçage cellulaire et procédé de fabrication correspondant |
Also Published As
| Publication number | Publication date |
|---|---|
| US11833346B2 (en) | 2023-12-05 |
| WO2016112315A3 (fr) | 2016-09-01 |
| US20210187280A1 (en) | 2021-06-24 |
| WO2016112315A2 (fr) | 2016-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11833346B2 (en) | Integrated circuits for neurotechnology and other applications | |
| Abbott et al. | Optimizing nanoelectrode arrays for scalable intracellular electrophysiology | |
| Xie et al. | Intracellular recording of action potentials by nanopillar electroporation | |
| Nam et al. | In vitro microelectrode array technology and neural recordings | |
| JP7245523B2 (ja) | 一体化した微小電極、及びそれを製造する方法 | |
| Shein et al. | Engineered neuronal circuits shaped and interfaced with carbon nanotube microelectrode arrays | |
| Lin et al. | Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease | |
| Kwiat et al. | Highly ordered large-scale neuronal networks of individual cells–Toward single cell to 3D nanowire intracellular interfaces | |
| Adams et al. | In vitro electrochemistry of biological systems | |
| US20210008363A1 (en) | Nanopillar electrode devices and methods of recording action potentials | |
| Kireev et al. | Graphene multielectrode arrays as a versatile tool for extracellular measurements | |
| Amin et al. | Biofunctionalized 3D nanopillar arrays fostering cell guidance and promoting synapse stability and neuronal activity in networks | |
| US20170363616A1 (en) | Patterned neuromuscular junctions and methods of use | |
| US20200292482A1 (en) | Electronic circuits for analyzing electrogenic cells and related methods | |
| US20170069860A1 (en) | Cell-based electromechanical biocomputing | |
| Desbiolles et al. | Nanovolcano microelectrode arrays: toward long-term on-demand registration of transmembrane action potentials by controlled electroporation | |
| Teixeira et al. | Gold‐mushroom microelectrode arrays and the quest for intracellular‐like recordings: perspectives and outlooks | |
| Koester et al. | Recording electric potentials from single adherent cells with 3D microelectrode arrays after local electroporation | |
| Xu et al. | Porous polyethylene terephthalate nanotemplate electrodes for sensitive intracellular recording of action potentials | |
| Lee et al. | Repeated and on-demand intracellular recordings of cardiomyocytes derived from human-induced pluripotent stem cells | |
| Maschietto et al. | In situ electroporation of mammalian cells through SiO2 thin film capacitive microelectrodes | |
| Chen et al. | Current-controlled electrical point-source stimulation of embryonic stem cells | |
| Stuber et al. | Interfacing Aptamer-Modified Nanopipettes with Neuronal Media and Ex Vivo Brain Tissue | |
| Simi et al. | Integration of microstructured scaffolds, neurons, and multielectrode arrays | |
| Sharf et al. | Non-contact monitoring of extra-cellular field potentials with a multi-electrode array |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, MASSACHU Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ABBOTT, JEFFREY TOWNSLEY;HAM, DONHEE;JORGOLLI, MARSELA;AND OTHERS;SIGNING DATES FROM 20160228 TO 20160331;REEL/FRAME:043136/0375 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
| AS | Assignment |
Owner name: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PARK, HONGKUN;HAM, DONHEE;ABBOTT, JEFFREY;AND OTHERS;SIGNING DATES FROM 20160228 TO 20160331;REEL/FRAME:057395/0307 |